Together with our mouse data, our results support the following scenario by which NPY variants promote atherosclerosis: presence of the rs16147 risk allele leads to increased plasma NPY levels, which, acting on NPY1 (and perhaps other) receptors, promotes arterial smooth muscle cell proliferation [30], thereby promoting atherogenesis. This evidence concerns the gene NPY and atherosclerosis.